Circulating tumor cells as a biomarker for monitoring: Disease progression, treatment response, and minimal residual disease. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback